FibroGen Inc (FGEN)
1.13
-0.04
(-3.42%)
USD |
NASDAQ |
May 02, 16:00
1.125
0.00 (0.00%)
Pre-Market: 20:00
FibroGen Accounts Payable (Quarterly): 17.96M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 17.96M |
September 30, 2023 | 19.22M |
June 30, 2023 | 12.80M |
March 31, 2023 | 71.28M |
December 31, 2022 | 30.76M |
September 30, 2022 | 19.32M |
June 30, 2022 | 29.36M |
March 31, 2022 | 36.35M |
December 31, 2021 | 26.10M |
September 30, 2021 | 23.87M |
June 30, 2021 | 48.99M |
March 31, 2021 | 24.06M |
December 31, 2020 | 24.79M |
September 30, 2020 | 7.553M |
June 30, 2020 | 5.015M |
March 31, 2020 | 2.865M |
December 31, 2019 | 6.088M |
September 30, 2019 | 4.055M |
June 30, 2019 | 4.06M |
March 31, 2019 | 3.772M |
Date | Value |
---|---|
December 31, 2018 | 9.139M |
September 30, 2018 | 10.13M |
June 30, 2018 | 3.222M |
March 31, 2018 | 3.549M |
December 31, 2017 | 5.509M |
September 30, 2017 | 6.407M |
June 30, 2017 | 3.261M |
March 31, 2017 | 2.95M |
December 31, 2016 | 6.223M |
September 30, 2016 | 2.039M |
June 30, 2016 | 3.474M |
March 31, 2016 | 1.543M |
December 31, 2015 | 6.521M |
September 30, 2015 | 4.234M |
June 30, 2015 | 3.915M |
March 31, 2015 | 2.433M |
December 31, 2014 | 4.551M |
September 30, 2014 | 2.895M |
June 30, 2014 | 1.256M |
December 31, 2013 | 1.066M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.865M
Minimum
Mar 2020
71.28M
Maximum
Mar 2023
21.82M
Average
19.32M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
Annovis Bio Inc | 1.293M |
Emergent BioSolutions Inc | 112.20M |
Geron Corp | 6.161M |
Vertex Pharmaceuticals Inc | 364.90M |
Regulus Therapeutics Inc | 0.204M |